Correction to: Nature Medicine https://doi.org/10.1038/s41591-018-0019-5, published online 8 July 2018.
In the version of this article originally published, information regarding several funding sources was omitted from the Acknowledgements section. The following sentences should have been included: “This work was supported by the generous philanthropic contributions to The University of Texas MD Anderson Lung Cancer Moon Shots Program, the UT Lung SPORE 5 P50 CA07090, and the MD Anderson Cancer Center Support Grant P30CA01667. V.P is supported by R01CA155196-01A1 from the National Cancer Institute.” Also, reference 18 was incorrect. The original reference was: Kim, E. S. et al. The BATTLE trial: personalizing therapy for lung cancer. Cancer Discov. 1, 44–53 (2011). It should have been: Papadimitrakopoulou, V. et al. The BATTLE-2 study: a biomarker-integrated targeted therapy study in previously treated patients with advanced non–small-cell lung cancer. J Clin. Oncol. 34, 3638–3647 (2016). The errors have been corrected in the HTML and PDF versions of this article.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Deribe, Y.L., Sun, Y., Terranova, C. et al. Author Correction: Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer. Nat Med 24, 1627 (2018). https://doi.org/10.1038/s41591-018-0173-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-018-0173-9
This article is cited by
-
Hyperbaric oxygen enhanced the chemotherapy of mitochondrial targeting molecule IR-780 in bladder cancer
Journal of Cancer Research and Clinical Oncology (2023)
-
BRD4 inhibition induces synthetic lethality in ARID2-deficient hepatocellular carcinoma by increasing DNA damage
Oncogene (2022)
-
Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy
Oncogene (2021)